SLC5A2 and Hyperglycemia: Our findings show that SGLT2 inhibition counteracts the hyperglycemia‐induced changes in plasma amino acid metabolism, potentially improving energy efficiency and metabolic health, though more research is needed to confirm these metabolic effects.